Nika Pharmaceuticals, Inc
NIKA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001145604
No open-market purchases or sales by Nika Pharmaceuticals, Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding NIKA, Q2 2026
No superinvestor reported holding NIKA at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Nika Pharmaceuticals, Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 19, 2025 (view filing)3:31 PM ET | Mar 18 | 1 day | Savov Dimitar SlavchevCEO, CFO, President | SSale | −2.00M | $0.25 | −$500.0K | −0.4%455.6M after | |
| Mar 19, 2024 (view filing)2:08 PM ET | Apr 13, 2022 | 706 daysLate | Nika Pharmaceuticals, IncPresident, CEO, CFO | PPurchaseCommon | +11.5M | $0.012 | +$137.9K | – | |
| Mar 19, 2024 (view filing)2:08 PM ET | Sep 12, 2022-Jun 2, 2023 | 554 daysLate | Nika Pharmaceuticals, IncPresident, CEO, CFO | SSaleCommon | −22.6M | $0.0182 | −$410.0K | – | 6 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Nika Pharmaceuticals, Inc at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding NIKA in 13F filings for Q2 2026.